Japan's Takeda Approved For Acquisition Of Shire

According to Reuters Takeda Pharmaceutical Co Ltd on Tuesday said it has received U.S. approval for its $62 billion acquisition of London-listed Shire Plc, taking the Japanese firm one step closer to its goal of becoming a global top 10 drugmaker. Takeda in a press release said it received unconditional clearance from the United States Federal Trade Commission. The Tokyo-listed firm is still awaiting approval from regulators in China, the European Union and elsewhere,.